INSIGHTS ON CLINICAL TRIAL DESIGN
-
Bridging The Gap Between Protocol And Execution In Clinical Trials
Transform passive trial operations into active infrastructure. Learn how a digitized execution layer builds in compliance, enables effective AI, and frees teams for critical decision-making.
-
What Everest Group's RTSM Recognition Means For The Industry
RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
Patient Trust And Engagement In The Age Of Decentralized Trials
To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.
-
Practical Strategies For Diverse Trial Recruitment
The clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.
-
DECODE CRS: Accelerating Immunotherapy Access And De-risking CRS6/18/2026
How does the DECODE CRS Coalition help trial sponsors standardize protocols and build a first-of-its-kind wearable dataset to lower development costs and safely de-risk outpatient care?
-
How To Drive Patient Engagement – The Power Of Concierge Support3/10/2025
In this discussion, our panel of experts will explore the critical role of concierge services in clinical trials, focusing on how these services address participant needs.
-
Your CRAs Aren't Monitoring. They're Managing Workarounds.5/11/2026
CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.
-
We Can Fix What's Broken in Research—If We Solve the Right Problems4/11/2025
Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.
-
Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?3/18/2026
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.